These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19364169)

  • 21. [Guidelines for the production, control and regulation of snake antivenom immunoglobulins].
    Chippaux JP
    Biol Aujourdhui; 2010; 204(1):87-91. PubMed ID: 20950580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Availability, affordability and stock-outs of commodities for the treatment of snakebite in Kenya.
    Ooms GI; van Oirschot J; Okemo D; Waldmann B; Erulu E; Mantel-Teeuwisse AK; van den Ham HA; Reed T
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009702. PubMed ID: 34398889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability, distribution and use of antivenoms for snakebite envenomation in Latin America: report of a workshop.
    Gutiérrez JM; Fan HW; Silvera CL; Angulo Y
    Toxicon; 2009 May; 53(6):625-30. PubMed ID: 19673076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Snakebite management in India, the first few hours: a guide for primary care physicians.
    Simpson ID
    J Indian Med Assoc; 2007 Jun; 105(6):324, 326, 328 passim. PubMed ID: 18232178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Confronting the neglected problem of snake bite envenoming: the need for a global partnership.
    Gutiérrez JM; Theakston RD; Warrell DA
    PLoS Med; 2006 Jun; 3(6):e150. PubMed ID: 16729843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of snakebites by the staff of a rural clinic: the impact of providing free antivenom in a nurse-led clinic in Meserani, Tanzania.
    Yates VM; Lebas E; Orpiay R; Bale BJ
    Ann Trop Med Parasitol; 2010 Jul; 104(5):439-48. PubMed ID: 20819312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of snakebite management practices at Meserani Juu in Monduli District, Northern Tanzania.
    Iddi S; Justin J; Hamasaki K; Konje ET; Kongola GW
    PLoS One; 2022; 17(12):e0278940. PubMed ID: 36548357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimates of disease burden due to land-snake bite in Sri Lankan hospitals.
    Kasturiratne A; Pathmeswaran A; Fonseka MM; Lalloo DG; Brooker S; de Silva HJ
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):733-40. PubMed ID: 16124448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific antivenom for Bungarus candidus.
    Leeprasert W; Kaojarern S
    J Med Assoc Thai; 2007 Jul; 90(7):1467-76. PubMed ID: 17710993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?
    Laustsen AH; Johansen KH; Engmark M; Andersen MR
    PLoS Negl Trop Dis; 2017 Feb; 11(2):e0005361. PubMed ID: 28158193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A survey of snakebite management knowledge amongst select physicians in Hong Kong and the implications for snakebite training.
    Fung HT; Lam SK; Lam KK; Kam CW; Simpson ID
    Wilderness Environ Med; 2009; 20(4):364-70. PubMed ID: 20030446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multicomponent strategy to improve the availability of antivenom for treating snakebite envenoming.
    Gutiérrez JM; Burnouf T; Harrison RA; Calvete JJ; Kuch U; Warrell DA; Williams DJ;
    Bull World Health Organ; 2014 Jul; 92(7):526-32. PubMed ID: 25110378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recent developments in diagnostic tools and bioanalytical methods for analysis of snake venom: A critical review.
    Puzari U; Mukherjee AK
    Anal Chim Acta; 2020 Nov; 1137():208-224. PubMed ID: 33153604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims.
    Harrison RA; Casewell NR; Ainsworth SA; Lalloo DG
    Trans R Soc Trop Med Hyg; 2019 Dec; 113(12):835-838. PubMed ID: 30668842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Assessment of the availability and use of antivenom in the district of Bamako, Mali, West Africa].
    Dramé BS; Dabo M; Diani N; Cissé B
    Bull Soc Pathol Exot; 2012 Aug; 105(3):179-83. PubMed ID: 22707256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Snakebite during pregnancy: a literature review.
    Langley RL
    Wilderness Environ Med; 2010 Mar; 21(1):54-60. PubMed ID: 20591355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Africa braced for snakebite crisis.
    Schiermeier Q
    Nature; 2015 Sep; 525(7569):299. PubMed ID: 26381961
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of snakebite in Australia: the current evidence base and questions requiring collaborative multicentre prospective studies.
    Currie BJ
    Toxicon; 2006 Dec; 48(7):941-56. PubMed ID: 16930660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving antivenom availability and accessibility: science, technology, and beyond.
    Gutiérrez JM
    Toxicon; 2012 Sep; 60(4):676-87. PubMed ID: 22781134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overlooked issues of snakebite management: time for strategic approach.
    Girish KS; Kemparaju K
    Curr Top Med Chem; 2011; 11(20):2494-508. PubMed ID: 21699494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.